Mercado global de tratamento da diarreia dos viajantes – Tendências do setor e previsão para 2028

Análise de Mercado e Insights: Mercado Global de Tratamento da Diarreia dos Viajantes

Espera-se que o mercado de tratamento da diarreia do viajante testemunhe um crescimento do mercado a uma taxa de 7,9% no período de previsão de 2021 a 2028. O relatório Data Bridge Market Research sobre o mercado de tratamento da diarreia do viajante fornece análises e insights sobre os vários fatores que devem ser predominantes em todo o mundo. O aumento dos casos de diarreia do viajante está a acelerar o crescimento do mercado de tratamento da diarreia do viajante.

A diarreia do viajante é uma perturbação do trato digestivo caracterizada por uma infeção abdominal que geralmente ocorre quando uma pessoa consome água ou alimentos contaminados. A diarreia do viajante afeta muitos viajantes internacionais que viajam para países emergentes todos os anos. Os alimentos e a água contaminada são as principais fontes de infecção. As bactérias, incluindo a E. coli e a Salmonella, são as causas mútuas da diarreia do viajante.

Os principais fatores que deverão impulsionar o crescimento do mercado de tratamento da diarreia do viajante no período de previsão são o aumento do turismo em todo o mundo. Além disso, prevê-se que o estilo de vida inativo e sedentário das pessoas impulsione ainda mais o crescimento do mercado de tratamento da diarreia do viajante. Além disso, estima-se que o baixo saneamento nas nações avançadas e subdesenvolvidas amorteça ainda mais o crescimento do mercado de tratamento da diarreia do viajante. Por outro lado, projeta-se que a escassez de conhecimento entre a população relacionada com o saneamento tanto nas nações avançadas como nos países subdesenvolvidos impeça o crescimento do mercado de tratamento da diarreia do viajante no período de tempo.

Além disso, o aumento dos gastos em todo o mundo proporcionará ainda mais oportunidades potenciais para o crescimento do mercado de tratamento da diarreia do viajante nos próximos anos. No entanto, os efeitos secundários nocivos dos medicamentos, incluindo a obstipação e a dor de cabeça, podem desafiar ainda mais o crescimento do mercado de tratamento da diarreia do Viajante num futuro próximo.

The Traveler's diarrhea treatment market report provides details of market share, new developments, and product pipeline analysis, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the Traveler's diarrhea treatment market scenario, contact Data bridge market research for an Analyst Brief. Our team will help you create a revenue impact solution to achieve your desired goal.

Global Traveler's Diarrhea Treatment Market Scope and Market Size

The Traveler's diarrhea treatment market is segmented on the basis of drugs class, drugs, route of administration, distribution channel and end user. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

• On the basis of drugs class, the Traveler's diarrhea treatment market is segmented into anti-motility agents, antibiotics and others.
• On the basis of drugs, the Traveler's diarrhea treatment market is segmented into synthetic material, biologically derived material, genetically engineered material and pharmaceutical.
• On the basis of route of administration, the Traveler's diarrhea treatment market is segmented into oral, parenteral.
• On the basis of distribution channel, the Traveler's diarrhea treatment market is segmented into pharmacy, online pharmacy, retail pharmacy.
• On the basis of end user, the Traveler's diarrhea treatment market is segmented into hospitals, homecare, specialty clinics and others.

Traveler's Diarrhea Treatment Market Country Level Analysis

The traveller’s diarrhea treatment market is analysed, and market size information is provided by country, drugs class, drugs, route of administration, distribution channel and end user as referenced above.

The countries covered in the Traveler's diarrhea treatment market report are the U.S., Canada, and Mexico in North America, Peru, Brazil, Argentina, and the rest of South America as part of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, rest of Europe in Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, rest of the Middle East and Africa (MEA) as a part of the Middle East and Africa (MEA).

North America dominates the Traveler's diarrhea treatment market due to the rise in the number of travellers. Furthermore, the occurrence of major key players will further boost the growth of the traveller’s diarrhea treatment market in the region during the forecast period. Asia-Pacific is projected to observe significant amount of growth in the traveller’s diarrhea treatment market due to the rise in the number of international travellers.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

The Traveler's diarrhea treatment market also provides you with detailed market analysis for patient analysis, prognosis, and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to the market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Traveler's Diarrhea Treatment Market Share Analysis

The Traveler's diarrhea treatment market competitive landscape provides details by a competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to the Traveler's diarrhea treatment market.

Os principais players abordados no relatório de mercado do tratamento da diarreia do viajante são a Bayer AG, Merck & Co., Inc, Johnson & Johnson Services, Inc., Novartis AG, Valneva SE, Shanghai United Cell Biotechnology Co., Ltd, PaxVax, Inc., Immuron, Salix Pharmaceuticals, F. Hoffmann-La Roche Ltd, Basilea Pharmaceutica Ltd, Eli Lilly and Company, Delcath Systems Inc., BridgeBio Inc., Incyte Corporation, Agios, Inc entre outros players nacionais e globais. Os dados de quota de mercado da medicina regenerativa estão disponíveis para a global, América do Norte, América do Sul, Europa, Ásia-Pacífico (APAC) e Médio Oriente e África (MEA) separadamente. Os analistas DBMR compreendem os pontos fortes competitivos e fornecem análises competitivas para cada concorrente em separado.

SKU-50478